Clinical trial
Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With…
NCT00109681 · Actelion, Industry · Completed
Key facts
| NCT number | NCT00109681 |
|---|---|
| Title | Inhaled Iloprost in Adults With Abnormal Pulmonary Pressure and Associated With Idiopathic Pulmonary Fibrosis |
| Official title | A Randomized, Double-blind, Placebo-Controlled Phase II Study to Evaluate the Safety and Pilot Efficacy of Iloprost Inhalation Solution in Adults With Abnormal Pulmonary Arterial Pressure and Exercise Limitation Associated With Idiopathic Pulmonary Fibrosis (IPF) |
| Lead sponsor | Actelion, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pulmonary Fibrosis, Pulmonary Hypertension |
| Intervention type | Drug |
| Interventions | Iloprost Inhalation Solution (Ventavis) |
| Enrollment | 50 |
| Start date | Apr 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 1, 2006 |
| First posted | May 3, 2005 |
| Last update posted | Feb 15, 2010 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: